Actinium Pharmaceuticals, Inc. (ATNM)
ATNM has a market cap or net worth of $119.41 million. The enterprise value is $37.36 million.
ATNM has 22.03 million shares outstanding. The number of shares has increased by 39.57% in one year.
|Shares Change (YoY)||+39.57%|
|Shares Change (QoQ)||+6.47%|
|Owned by Insiders (%)||1.41%|
|Owned by Institutions (%)||14.05%|
|EV / Earnings||n/a|
|EV / Sales||33.32|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 19.87, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -31.60%, which is considered low.
|Return on Equity (ROE)||-31.60%|
|Return on Assets (ROA)||-29.80%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||$35,031|
|Profits Per Employee||-$723,250|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -35.24% in the last 52 weeks. The beta is 0.53, so ATNM's price volatility has been lower than the market average.
|52-Week Price Change||-35.24%|
|50-Day Moving Average||6.28|
|200-Day Moving Average||7.08|
|Average Volume (30 Days)||128,262|
Short Selling Information
|Short % of Shares Out||3.89%|
|Short % of Float||3.95%|
|Short Ratio (days to cover)||6.01|
In the last 12 months, ATNM had revenue of $1.12 million and -23.14 million in losses. Earnings per share was -$1.22.
|Earnings Per Share (EPS)||-$1.22|
The company has $82.47 million in cash and $421,000 in debt, giving a net cash position of $82.05 million or $3.72 per share.
|Cash & Cash Equivalents||82.47M|
|Net Cash Per Share||$3.72|
|Book Value Per Share||3.64|
In the last 12 months, operating cash flow was -$22.07 million and capital expenditures -$378,000, giving a free cash flow of -$22.45 million.
|Operating Cash Flow||-22.07M|
|Free Cash Flow||-22.45M|
|FCF Per Share||n/a|
Gross margin is 100.00%, with operating and profit margins of -2,083.05% and -2,064.59%.
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.
|Last Split Date||Aug 11, 2020|